Highly convergent three component benzyne coupling: The total synthesis of ent-clavilactone B

Journal of the American Chemical Society

Volumn 128, Issue 43, 2006, Pages 14042-14043

  Larrosa, Igor ^a   Da Silva, Marianne I ^a   Gómez, Patricio M ^a   Hannen, Peter ^a   Ko, Eunjung ^a   Lenger, Steven R ^b   Linke, Simon R ^b   White, Andrew J P ^a   Wilton, Donna ^a   Barrett, Anthony G M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLAVILACTONE B; LACTONE DERIVATIVE; PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; ASYMMETRIC SYNTHESIS; CARBON NUCLEAR MAGNETIC RESONANCE; EPIMERIZATION; EPOXIDATION; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; REDUCTION; SWERN OXIDATION;

BENZENE DERIVATIVES; CATALYSIS; ISOMERISM; LACTONES;

EID: 33750435912     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja0662671     Document Type: Article

References (30)

1. Arnone, A.; Cardillo, R.; Meille, S. V.; Nasini, G.; Tollazi, M. J. Chem. Soc., Perkin Trans. 1 1994, 2165.
2. Merlini, L.; Nasini, G.; Scaglioni, L.; Cassinelli, G.; Lanzi, C. Phytochemistry 2000, 53, 1039.
3. Cassinelli, G.; Lanzi, C.; Pensa, T.; Gambetta, R. A.; Nasini, G.; Cuccuru, G.; Cassinis, M.; Pratesi, G.; Polizzi, D.; Tortoreto, M.; Zunino, F. Biochem. Pharmacol. 2000, 59, 1539.
4. Courtneidge, S. A. Semin. Cancer Biol. 1994, 5, 239.
5. Van der Geer, P.; Hunter, T.; Lindberg, R. A. Annu. Rev. Cell. Biol. 1994, 10, 251.
6. (a) Morton, G. E.; Barrett, A. G. M. J. Org. Chem. 2005, 70, 3525.
7. (b) Morton, G. E.; Barrett, A. G. M. Org. Lett. 2006, 8, 2859.
8. For related three-component benzyne coupling: (a) Pansegrau, P. D.; Rieker, W. F.; Meyers, A. I. J. Am. Chem. Soc. 1988, 110, 7178.
9. (b) Yoshida, H.; Fukushima, H.; Oshita, J.; Kunai, A. Angew. Chem., Int. Ed. 2004, 43, 3935.
10. (e) Tomori, H.; Fox, J. M.; Buchwald, S. L. J. Org. Chem. 2000, 65, 5334.
11. For a review see (d) Hoffmann, R. W. Dehydrobenzene and Cycloalkynes; Academic Press: New York, 1967.
12. Anderson, R. J.; Corbin, V. L.; Cotterrell, G.; Cox, G. R.; Henrick, C. A.; Schaub, F.; Siddall, J. B. J. Am. Chem. Soc. 1975, 97, 1197.
13. Hanson, R. M.; Sharpless, K. B. J. Org. Chem. 1986, 51, 1922.
14. (a) Stoichiometric Sharpless epoxidation was required.
15. (b) Enantiomeric excess determined by chiral HPLC. See Supporting Information.
16. Pellissier, H.; Santelli, M. Tetrahedron 2003, 59, 701.
17. See Supporting Information for details of stereochemical assignments of all compounds, including 2.
18. (a) Howe, G. P.; Wang, S.; Procter, G. Tetrahedron Lett. 1987, 28, 2629.
19. (b) For a review see Mengel, A.; Reiser, O. Chem. Rev. 1999, 99, 1191.
20. The diastereoselectivity of the 3-component coupling was not affected by changing the metal, solvent, additives, or the protecting group in 9.
21. Larsen, C. H.; Ridgway, B. H.; Shaw, J. T.; Woerpel, K. A. J. Am. Chem. Soc. 1999, 121, 12208.
22. De Mico, A.; Margarita, R.; Parlanti, L.; Vescovi, A.; Piancatelli, G. J. Org. Chem. 1997, 62, 6974.
23. For an example of such an epimerization. See Barluenga, J.; Viado, A. L.; Aguilar, E.; Fustero, S.; Olano, B. J. Org. Chem. 1993, 58, 5972.
24. Saito, S.; Yamamoto, H. Chem. Commun. 1997, 1585.
25. 3Al was unsuccessful.
26. Studies to determine the actual structure of 21 are underway.
27. Generally, dimerization of the more reactive monosubstituted olefin occurs first which may be reversible. In contrast, macrocyclization is usually irreversible. See (a) Fürstner, A.; Thiel, O. R.; Ackermann, L. Org. Lett. 2001, 3, 449.
28. (b) Crimmins, M. T.; Brown, B. H. J. Am. Chem. Soc. 2004, 126, 10264.
29. Hong, S. H.; Sanders, D. P.; Lee, C. W.; Grubbs, R. H. J. Am. Chem. Soc. 2005, 127, 17160.
30. Eskildsen, J.; Reenberg, T.; Christensen, J. B. Eur. J. Org. Chem. 2000, 1637.